Performance of PEN‐FAST and CEPH‐FAST for Cephalosporin Allergy Delabeling
Clinical and Translational Allergy · 2026-06 · 16 (6)
DOI: 10.1002/clt2.70178 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Allergy, online erschienen am 27.05.2026. Verfasst von Deniz Göcebe und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University Hospital Heidelberg, Heidelberg, Germany. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Background
Unverified antibiotic allergy labels lead to suboptimal antimicrobial prescribing and increased antibiotic resistance. Cephalosporins are among the most frequently administered antibiotics and cephalosporin allergy labels increasingly limit optimal therapy. Clinical decision rules that enable delabeling of low‐risk patients by non‐allergists are emerging as important tools. The PEN‐FAST score is a validated rule for identifying low‐risk penicillin allergy labels suitable for direct drug challenge. CEPH‐FAST is a recently proposed adaptation for cephalosporin allergy. We evaluated the diagnostic performance of PEN‐FAST and CEPH‐FAST for cephalosporin allergy.
Methods
In this single‐center retrospective cohort study, 100 adults with reported cephalosporin allergy labels underwent allergy assessment including skin testing and drug provocation testing at a tertiary allergy clinic in Heidelberg, Germany. Logistic regression was used to identify predictors of confirmed allergy. Diagnostic performance of PEN‐FAST and CEPH‐FAST scores was assessed using sensitivity, specificity, predictive values, and area under the receiver operating curve (AU‐ROC).
Results
Cephalosporin allergy was confirmed in 48 of 100 patients. PEN‐FAST categorized 20 patients at low risk, of whom one had a positive skin test (NPV 95.0%, sensitivity 97.9%, AU‐ROC 0.769). CEPH‐FAST classified 42 patients low‐risk, but 12 had confirmed allergies (NPV 71.4%, sensitivity 75.0%, AU‐ROC 0.667). Higher PEN‐FAST and CEPH‐FAST scores were significantly associated with confirmed allergy.
Conclusion
PEN‐FAST demonstrated high sensitivity and negative predictive value for identifying low‐risk cephalosporin allergy and may support safe delabeling strategies. In contrast, CEPH‐FAST showed reduced diagnostic performance in this cohort, highlighting the need for further validation before routine clinical implementation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, University Hospital Heidelberg, Heidelberg, Germany.
- Department of Cardiology, Angiology and Pneumology, University Hospital Heidelberg, Heidelberg, Germany.
- Hospital Pharmacy, University Hospital Heidelberg, Heidelberg, Germany.
- Department of Infectious Diseases and Tropical Medicine, Center for Infectious Diseases, University Hospital Heidelberg, Heidelberg, Germany.
- German Center for Infection Research (DZIF), Partner Site Heidelberg University Hospital, Heidelberg, Germany.
ORCID-Profile: Deniz Göcebe, Knut Schäkel
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Göcebe, D., Nürnberg, H., Enk, A., Khatamzas, E., & Schäkel, K. (2026). Performance of PEN‐FAST and CEPH‐FAST for Cephalosporin Allergy Delabeling. Clinical and Translational Allergy, 16(6). https://doi.org/10.1002/clt2.70178
Vancouver
Göcebe D, Nürnberg H, Enk A, Khatamzas E, Schäkel K. Performance of PEN‐FAST and CEPH‐FAST for Cephalosporin Allergy Delabeling. Clinical and Translational Allergy. 2026;16(6). doi:10.1002/clt2.70178
BibTeX
@article{Gcebe2026,
author = {Göcebe, Deniz and Nürnberg, Hannah and Enk, Alexander and Khatamzas, Elham and Schäkel, Knut},
title = {Performance of PEN‐FAST and CEPH‐FAST for Cephalosporin Allergy Delabeling},
journal = {Clinical and Translational Allergy},
year = {2026},
volume = {16},
number = {6},
doi = {10.1002/clt2.70178}
}
EUVIMED